Jinyan Xiao
Suzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Venetoclax-based combination regimens for therapy-related myeloid neoplasms.
Journal: International journal of hematology
Published: October 21, 2025
Better Response and Prognosis of Venetoclax Plus Hypomethylating Agents Over Intensive Chemotherapy in Young Adults With Newly Diagnosed ASXL1-Mutated Acute Myeloid Leukemia.
Journal: Cancer medicine
Published: January 17, 2025
Clinical Outcomes of CD7 CAR-T Cell Therapy in Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Patients.
Journal: Hematological oncology
Published: November 04, 2024
Prognostic significance of persisting DNMT3A, ASXL1, and TET2 mutation burden in acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation during complete remission.
Journal: Leukemia & lymphoma
Published: November 22, 2023
RUNX1 together with DAT mutations predicted poor outcome in acute myeloid leukemia.
Journal: Leukemia & lymphoma
Published: March 25, 2023
Recurrent Novel P2RY8/IGH Translocations in B-Lymphoblastic Leukemia/Lymphoma.
Journal: Frontiers in oncology
Published: March 15, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026